Rapid antimicrobial susceptibility testing for gram-negative blood infections shows no improvement in clinical outcomes ...

More than 3 million bottles of eye drops have been pulled from shelves after testing failures raised contamination ...

A new study suggests that a urine-based biomarker test shows promise in forecasting bladder cancer treatment response, which ...

The vision of a single blood test that could screen for dozens of different cancers has tantalized oncologists for more than ...

ApoB testing outperforms traditional cholesterol measures in preventing heart attacks and strokes while remaining ...

Scientists have developed a fecal-sampling method that can help identify illegally captured wild birds in Latin America that ...

MethylScan is a low-cost blood test that detects cancers and organ diseases by analyzing DNA methylation, improving early diagnosis, and identifying disease origin.

As drug development becomes more complex, so do the demands for accurate, reproducible bioanalytical data to prove their safety and efficacy. Method validation ensures the reliability of ...

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...

Liver scarring can pave the way to cancer down the line. A new blood test in development might help doctors spot it.